Cargando…
Candida auris: A Quick Review on Identification, Current Treatments, and Challenges
Candida auris is a novel and major fungal pathogen that has triggered several outbreaks in the last decade. The few drugs available to treat fungal diseases, the fact that this yeast has a high rate of multidrug resistance and the occurrence of misleading identifications, and the ability of forming...
Autores principales: | Černáková, Lucia, Roudbary, Maryam, Brás, Susana, Tafaj, Silva, Rodrigues, Célia F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123192/ https://www.ncbi.nlm.nih.gov/pubmed/33922907 http://dx.doi.org/10.3390/ijms22094470 |
Ejemplares similares
-
Overview on the Infections Related to Rare Candida Species
por: Kumar, Sunil, et al.
Publicado: (2022) -
Combination of Farnesol with Common Antifungal Drugs: Inhibitory Effect against Candida Species Isolated from Women with RVVC
por: Nikoomanesh, Fatemeh, et al.
Publicado: (2023) -
Overview on the Prevalence of Fungal Infections, Immune Response, and Microbiome Role in COVID-19 Patients
por: Roudbary, Maryam, et al.
Publicado: (2021) -
Photodynamic Inactivation Effectively Eradicates Candida auris Biofilm despite Its Interference with the Upregulation of CDR1 and MDR1 Efflux Genes
por: Štefánek, Matúš, et al.
Publicado: (2022) -
Farnesol and Tyrosol: Secondary Metabolites with a Crucial quorum-sensing Role in Candida Biofilm Development
por: Rodrigues, Célia F., et al.
Publicado: (2020)